Skip to main content
. 2022 Apr 18;40(23):3159–3164. doi: 10.1016/j.vaccine.2022.04.045

Fig. 3.

Fig. 3

Kaplan-Meier survival curve representing the incidence of SARS-CoV-2 infection with the delay from complete vaccination as a time-dependent variable. A) Kaplan-Meier survival curve representing overall incidence of SARS-CoV-2 infection with time. B) Kaplan-Meier survival curve representing overall incidence of SARS-CoV-2 infection according to vaccine schemes with time. The red curve corresponds to scheme with BNT162b2, the blue to scheme with mRNA-1273, green schemes including ChAdOx1 nCoV-19 and purple mixed mRNA schemes. No difference was found between the different vaccine schemes (P = 0.42) in the incidence of SARS-CoV-2 infection taking the delay as the time-dependent variable, compared using a Log-Rank test. Time is given in days. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)